Vasotec and Dermatitis exfoliative - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative is reported as a side effect among people who take Vasotec (enalapril maleate), especially for people who are female, 60+ old, also take Glyburide, and have Gout.

The phase IV clinical study analyzes which people have Dermatitis exfoliative when taking Vasotec. It is created by eHealthMe based on reports of 14,393 people who have side effects when taking Vasotec from the FDA, and is updated regularly.

What is Vasotec?

Vasotec has active ingredients of enalapril maleate. It is often used in high blood pressure. eHealthMe is studying from 14,646 Vasotec users. Check the latest studies of Vasotec.

What is Dermatitis exfoliative?

Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 688 drugs and 945 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative.

On Jul, 04, 2026

14,393 people reported to have side effects when taking Vasotec.
Among them, 12 people (0.08%) have Dermatitis exfoliative.

Could Vasotec cause Dermatitis exfoliative?

Among these 12 people:

What is the gender of people who have Dermatitis exfoliative when taking Vasotec? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Dermatitis exfoliative when taking Vasotec? *

What are other drugs people take besides Vasotec? *

What are other side effects people have besides Dermatitis exfoliative? *

Rash Erythematous (redness of the skin): 4 people, 33.33%
Weakness: 3 people, 25.00%
Rashes (redness): 3 people, 25.00%
Fever: 3 people, 25.00%
Epidermal Necrolysis (skin condition that is usually caused by a reaction to drugs): 3 people, 25.00%
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 3 people, 25.00%
Rash Pruritic (redness with itching): 3 people, 25.00%
Hair Loss: 3 people, 25.00%
Rash Scaly: 2 people, 16.67%
Scab (a hard coating on the skin formed during the wound healing): 2 people, 16.67%

What are the existing conditions these people have? *

Gout (uric acid crystals building up in the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Vasotec and have Dermatitis exfoliative?

- Check whether Dermatitis exfoliative is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vasotec:

Vasotec (14,646 reports)

Browse all side effects of Vasotec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (688 drugs)

Browse all the conditions that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (945 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enalapril maleate (the active ingredients of Vasotec) and Vasotec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.